161 related articles for article (PubMed ID: 3034850)
21. Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
Stromberg BV; Reines HD; Hunt P
Surg Gynecol Obstet; 1986 Jun; 162(6):575-8. PubMed ID: 3012808
[TBL] [Abstract][Full Text] [Related]
22. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
23. Beta-lactamase production and the role of ampicillin/sulbactam.
Alpuche-Aranda CM
Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S8-11; discussion S20-1. PubMed ID: 9519908
[No Abstract] [Full Text] [Related]
24. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections.
Rev Infect Dis; 1986; 8 Suppl 5():S583-8. PubMed ID: 2879345
[TBL] [Abstract][Full Text] [Related]
25. Sulbactam/ampicillin in the treatment of acute epiglottitis in children.
Wald E; Reilly JS; Bluestone CD; Chiponis D
Rev Infect Dis; 1986; 8 Suppl 5():S617-9. PubMed ID: 3026014
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of sulbactam plus ampicillin in gynecologic infections.
Giamarellou H; Trouvas G; Avlami A; Aravantinos D; Daikos GK
Rev Infect Dis; 1986; 8 Suppl 5():S579-82. PubMed ID: 3026007
[TBL] [Abstract][Full Text] [Related]
27. Sulbactam/ampicillin versus cefotaxime as initial therapy in serious soft tissue, joint and bone infections.
Löffler L; Bauernfeind A; Keyl W
Drugs; 1988; 35 Suppl 7():46-52. PubMed ID: 3265378
[TBL] [Abstract][Full Text] [Related]
28. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
Jauregui L; Minns P; Hageage G
J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
[TBL] [Abstract][Full Text] [Related]
29. An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections.
Löffler L; Bauernfeind A; Keyl W; Hoffstedt B; Piergies A; Lenz W
Rev Infect Dis; 1986; 8 Suppl 5():S593-8. PubMed ID: 3026009
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic and therapeutic trial of sultamicillin in acute sinusitis.
Jones S; Yu VL; Johnson JT; Wagner RL; Kim HK
Antimicrob Agents Chemother; 1985 Dec; 28(6):832-3. PubMed ID: 3002247
[TBL] [Abstract][Full Text] [Related]
31. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of beta-lactamase-induced resistance in soft-tissue infections.
Nichols RL; Smith JW; Adinolfi MF; Galli R; Vivoda LM
Arch Surg; 1985 Jan; 120(1):36-42. PubMed ID: 2981523
[TBL] [Abstract][Full Text] [Related]
33. Sultamicillin (CP-49, 952): evaluation of two dosage schedules in urinary infection.
Ball AP; Fox C; Ghosh D
J Antimicrob Chemother; 1984 Oct; 14(4):395-401. PubMed ID: 6094422
[TBL] [Abstract][Full Text] [Related]
34. Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections.
Senft HH; Stiglmayer R; Eibach HW; Koerner H
Drugs; 1986; 31 Suppl 2():18-21. PubMed ID: 3013568
[TBL] [Abstract][Full Text] [Related]
35. [In vitro activity of ampicillin and ampicillin-sulbactam on diverse bacteria].
Trucco O; Prado V; Mollinedo E; Cordoves A
Rev Med Chil; 1989 Jul; 117(7):747-54. PubMed ID: 2519428
[TBL] [Abstract][Full Text] [Related]
36. Sultamicillin--a new antibiotic in the treatment of persistent lower respiratory tract infections caused by Haemophilus influenzae.
Pressler T; Pedersen SS; Christiansen L; Szaff M; Koch C; Høiby N
J Antimicrob Chemother; 1986 Apr; 17(4):529-33. PubMed ID: 3011725
[TBL] [Abstract][Full Text] [Related]
37. Sultamicillin (ampicillin-sulbactam) in the treatment of acute otitis media in children.
Kaleida PH; Bluestone CD; Blatter MM; Reisinger KS; Wucher FP; Fall PA; Rohn DD
Pediatr Infect Dis; 1986; 5(1):33-8. PubMed ID: 3003716
[TBL] [Abstract][Full Text] [Related]
38. [Clinical evaluation of sulbactam/ampicillin in children].
Ito S; Mayumi M; Ito M; Mikawa H
Jpn J Antibiot; 1989 Mar; 42(3):675-85. PubMed ID: 2664251
[TBL] [Abstract][Full Text] [Related]
39. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Friedel HA; Campoli-Richards DM; Goa KL
Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
[TBL] [Abstract][Full Text] [Related]
40. Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections.
Crombleholme WR; Ohm-Smith M; Robbie MO; DeKay V; Sweet RL
Am J Obstet Gynecol; 1987 Feb; 156(2):507-12. PubMed ID: 3030109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
